ACYW135 meningococcal polysaccharide conjugate vaccine(NPO Petrovax)(ACYW135 meningococcal polysaccharide conjugate vaccine(NPO Petrovax))

概要

基本信息

药物类型

预防性疫苗

别名

GNG-DE、Polysaccharide conjugated vaccine for prevention of meningococcal infection of serogroups A, C, W, Y

靶点-

作用方式-

作用机制-

治疗领域

感染

在研适应症

脑膜炎球菌感染

非在研适应症-

原研机构

NPO Petrovax Pharm Ltd.

在研机构

NPO Petrovax Pharm Ltd.

非在研机构-

权益机构-

最高研发阶段临床3期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

3

项与 ACYW135 meningococcal polysaccharide conjugate vaccine(NPO Petrovax) 相关的临床试验

NCT06834100

/ Not yet recruiting临床3期

Simple Blinded Multicenter Randomized Comparative Study to Assess Immunogenicity, Reactogenicity and Safety of the Drug GNG-DE

Assessment of immunogenicity, reactogenicity and safety of GNG-DE in comparison with the reference drug

开始日期2025-02-12

申办/合作机构

NPO Petrovax Pharm Ltd.

ChiCTR2200058397

/ Suspended临床3期IIT

A phase III clinical study to evaluate the immunogenicity and safety of Groups ACYW135 Meningococcal Polysaccharide Conjugate Vaccine in healthy subjects aged 2 to 6 years old, 7 to 17 years old and 18 to 55 years old

开始日期2022-04-16

申办/合作机构-

ChiCTR2200058396

/ Suspended临床3期IIT

A phase III clinical study to evaluate the immunogenicity and safety of Groups ACYW135 Meningococcal Polysaccharide Conjugate Vaccine in healthy subjects aged 6 to 23 months

开始日期2022-03-30

申办/合作机构-

100 项与 ACYW135 meningococcal polysaccharide conjugate vaccine(NPO Petrovax) 相关的临床结果

登录后查看更多信息

100 项与 ACYW135 meningococcal polysaccharide conjugate vaccine(NPO Petrovax) 相关的转化医学

登录后查看更多信息

100 项与 ACYW135 meningococcal polysaccharide conjugate vaccine(NPO Petrovax) 相关的专利（医药）

登录后查看更多信息

100 项与 ACYW135 meningococcal polysaccharide conjugate vaccine(NPO Petrovax) 相关的药物交易

登录后查看更多信息